homemarket NewsUS FDA issues Establishment Inspection Report for Alkem Labs API manufacturing unit at Mandva

US FDA issues Establishment Inspection Report for Alkem Labs API manufacturing unit at Mandva

The US FDA inspected Mandva’s API manufacturing facility on December 1, 2023.

Profile image

By CNBCTV18.com Feb 28, 2024 4:10:41 PM IST (Published)

Listen to the Article(6 Minutes)
1 Min Read
US FDA issues Establishment Inspection Report for Alkem Labs API manufacturing unit at Mandva
The US FDA issues Establishment Inspection Report (EIR) for Mandva’s API manufacturing facility and the inspection has been classified as Voluntary Action Indicated (VAI).

Share Market Live

View All

"This is to inform you that US FDA has issued an Establishment Inspection Report for the said manufacturing facility. The Inspection has been classified as Voluntary Action Indicated (VAI) and was closed accordingly," the company said in an exchange filing.
The US FDA inspected Mandva’s API manufacturing facility on December 1, 2023.
Shares of Alkem Laboratories Ltd settle 0.91% lower at 4,998 apiece on NSE today. The stock fell 2.38% so far this year.

Most Read

Share Market Live

View All
Top GainersTop Losers
CurrencyCommodities
CurrencyPriceChange%Change